Cloning of the TIS gene suppressed by topoisomerase inhibitors

• Published in: Gene 1998-07, Vol.215 (2), p.453-459
• Main Authors: Onishi, Yoshiaki, Hashimoto, Sadamitsu, Kizaki, Harutoshi
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Camptothecin; Camptothecin - pharmacology; Cloning, Molecular - drug effects; COS Cells; DNA, Complementary; Exons; Gene structure; Genes, Reporter; Genomic Library; Liver - metabolism; Lymphoma; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Promoter Regions, Genetic; Protein Biosynthesis; Proteins - genetics; Recombinant Proteins - biosynthesis; Restriction Mapping; RNA-Binding Proteins; Sequence Deletion; TATA Box; Topoisomerase; Topoisomerase I Inhibitors; Transcription, Genetic; Transfection; Tumor Cells, Cultured
• ISSN: 0378-1119; 1879-0038
• DOI: 10.1016/S0378-1119(98)00313-8

We recently cloned the cDNA TIS (topoisomerase inhibitor-suppressed) in RVC lymphoma cells exposed to the topoisomerase inhibitors. To elucidate the suppression mechanism of the TIS mRNA by camptothecin, we characterized the structures of the TIS gene. The gene spanned about 21 kb including 11 exons and was present as a single copy. The putative transcription site was present 192 bp upstream from the ATG codon. The typical TATA sequence and CCAAT promoter element were located at positions −21 and −81, respectively. The unidirectional deletion analysis of the 5′-flanking region revealed that [−132/+160] is the promoter region, which participates in the responsiveness to camptothecin. A Northern blot analysis showed that the TIS was expressed in most mouse tissues; at the highest level in the liver and to less extent in the heart and skeletal muscle. The present study showed that the expression of the TIS is suppressed at the transcriptional level by camptothecin. Considering that topoisomerase I is an essential enzyme in mammalian cells, the TIS protein may have an important role in camptothecin toxicity.